Lindbrook Capital’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $4.59K | Buy |
696
+617
| +781% | +$4.07K | ﹤0.01% | 1983 |
|
|
2024
Q4 | $688 | Sell |
79
-10
| -11% | -$87 | ﹤0.01% | 2550 |
|
|
2024
Q3 | $1.74K | Sell |
89
-118
| -57% | -$2.31K | ﹤0.01% | 2390 |
|
|
2024
Q2 | $4.26K | Buy |
207
+102
| +97% | +$2.1K | ﹤0.01% | 2073 |
|
|
2024
Q1 | $2.24K | Buy |
105
+23
| +28% | +$491 | ﹤0.01% | 2202 |
|
|
2023
Q4 | $1.18K | Buy |
+82
| New | +$1.18K | ﹤0.01% | 2430 |
|
|
2023
Q3 | – | Sell |
-245
| Closed | -$2.59K | – | 2776 |
|
|
2023
Q2 | $2.59K | Sell |
245
-905
| -79% | -$9.58K | ﹤0.01% | 2048 |
|
|
2023
Q1 | $14.1K | Buy |
1,150
+715
| +164% | +$8.75K | ﹤0.01% | 1244 |
|
|
2022
Q4 | $5.4K | Sell |
435
-229
| -34% | -$2.84K | ﹤0.01% | 1787 |
|
|
2022
Q3 | $9K | Sell |
664
-76
| -10% | -$1.03K | ﹤0.01% | 1376 |
|
|
2022
Q2 | $14K | Sell |
740
-59
| -7% | -$1.12K | ﹤0.01% | 1127 |
|
|
2022
Q1 | $13K | Sell |
799
-1,079
| -57% | -$17.6K | ﹤0.01% | 1189 |
|
|
2021
Q4 | $26K | Buy |
1,878
+1,771
| +1,655% | +$24.5K | ﹤0.01% | 929 |
|
|
2021
Q3 | $2K | Hold |
107
| – | – | ﹤0.01% | 1559 |
|
|
2021
Q2 | $2K | Hold |
107
| – | – | ﹤0.01% | 1605 |
|
|
2021
Q1 | $3K | Hold |
107
| – | – | ﹤0.01% | 1425 |
|
|
2020
Q4 | $3K | Hold |
107
| – | – | ﹤0.01% | 1343 |
|
|
2020
Q3 | $3K | Hold |
107
| – | – | ﹤0.01% | 1281 |
|
|
2020
Q2 | $2K | Hold |
107
| – | – | ﹤0.01% | 1402 |
|
|
2020
Q1 | $1K | Buy |
+107
| New | +$1K | ﹤0.01% | 1490 |
|